Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.48 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.47 |
| ▸ | CPB2 | Q96IY4 | 6/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | PLG | P00747 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | GABRR1 | P24046 | 3/20 | 0.37 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14890176 | 1.00 | GSR (0.48) | GSRRNPEPCPB2FOLH1CYP2D6 | |
| SCHEMBL158632 | 1.00 | GSR (0.48) | GSRRNPEPCPB2FOLH1CYP2D6 | |
| SCHEMBL24075891 | 1.00 | GSR (0.48) | GSRRNPEPCPB2FOLH1CYP2D6 | |
| SCHEMBL7166159 | 0.98 | GSR (0.47) | GSRRNPEPCPB2FOLH1CYP2D6 | |
| SCHEMBL7107141 | 0.98 | GSR (0.47) | GSRRNPEPCPB2FOLH1CYP2D6 | |
| Water SCHEMBL28962316 | 0.98 | GSR (0.47) | GSRRNPEPCPB2FOLH1CYP2D6 | |
| Water SCHEMBL1007984 | 0.98 | GSR (0.47) | GSRRNPEPCPB2FOLH1CYP2D6 | |
| SCHEMBL388186 | 0.98 | GSR (0.47) | GSRRNPEPCPB2FOLH1CYP2D6 | |
| SCHEMBL6270473 | 0.98 | GSR (0.47) | GSRRNPEPCPB2FOLH1CYP2D6 | |
| SCHEMBL7069551 | 0.90 | GSR (0.41) | GSRRNPEPCPB2FOLH1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 520 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12569439-B2 | Bottom-up assembly of synthetic extracellular vesicles | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-03-10 | — | — | US | claimed |
| US-20250332101-A1 | Composition | CORDEIRO MARIA FRANCESCA (GB) | 2025-10-30 | — | — | US | claimed |
| CN-115015551-B | Immunodetection method for effectively reducing steric hindrance by directionally binding Fc locus of antibody | 上海云泽生物科技有限公司 | 2025-06-17 | — | — | CN | claimed |
| WO-2025103294-A1 | FUSION PROTEIN AND USE THEREOF | 维康平生(北京)生物科技有限公司 | 2025-05-22 | — | — | WO | claimed |
| CN-115605434-B | Preparation of cerium (III) carbonate dispersions | 加利福尼亚大学董事会 | 2025-02-11 | — | — | CN | claimed |
| CN-119307163-A | Non-stick pan coating, preparation method thereof and pan | 河北立德尔炊具股份有限公司 | 2025-01-14 | — | — | CN | claimed |
| EP-4459286-A1 | KIT FOR QUANTITATIVELY DETERMINING TACROLIMUS IN WHOLE BLOOD BY LOW-RESISTANCE LATEX-ENHANCED IMMUNE COMPETITION METHOD, AND USE THEREOF | SHANGHAI YUNZE BIOTECHNOLOGY CO., LTD (CN) | 2024-11-06 | — | — | EP | claimed |
| CN-118027547-A | Flame-retardant solar photovoltaic cable | 山东趵突泉线缆有限公司 | 2024-05-14 | — | — | CN | claimed |
| US-11964026-B2 | Layer-by-layer nanoparticles for cytokine therapy in cancer treatment | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2024-04-23 | — | — | US | claimed |
| CN-115015547-B | Kit for quantitatively determining tacrolimus in whole blood by low-steric-hindrance latex-enhanced immune competition method | 上海云泽生物科技有限公司 | 2024-04-12 | — | — | CN | claimed |
| EP-1962894-A2 | METHOD FOR ASSEMBLING A POLYMER-BIOLOGIC DELIVERY COMPOSITION | Medivas, LLC (US) | 2008-09-03 | — | — | EP | claimed |
| EP-1817582-A2 | POLYMER-COATED SUBSTRATES FOR BINDING BIOMOLECULES AND METHODS OF MAKING AND USING THEREOF | Corning Incorporated (US) | 2007-08-15 | — | — | EP | claimed |
| US-20070160622-A1 | Method for assembling a polymer-biologic delivery composition | MEDIVAS, LLC (US) | 2007-07-12 | — | — | US | claimed |
| WO-2007067744-A2 | METHOD FOR ASSEMBLING A POLYMER-BIOLOGIC DELIVERY COMPOSITION | MEDIVAS, LLC (US) | 2007-06-14 | — | — | WO | claimed |
| WO-2006058237-A2 | POLYMER-COATED SUBSTRATES FOR BINDING BIOMOLECULES AND METHODS OF MAKING AND USING THEREOF | CORNING INCORPORATED (US) | 2006-06-01 | — | — | WO | claimed |
| US-20060110594-A1 | Polymer-coated substrates for binding biomolecules and methods of making and using thereof | CORNING INCORPORATED | 2006-05-25 | — | — | US | claimed |
| EP-1011730-A2 | TARGETED ADDITION OF SOLUBLE POLYMERS TO RECOMBINANT PROTEINS | Edge Biosystems, Inc. (US) | 2000-06-28 | — | — | EP | claimed |
| WO-1998015293-A2 | TARGETED ADDITION OF SOLUBLE POLYMERS TO RECOMBINANT PROTEINS | EDGE BIOSYSTEMS, INC. (US) | 1998-04-16 | — | — | WO | claimed |
| EP-0253303-B1 | METAL CHELATING RESINS | F. HOFFMANN-LA ROCHE AG (CH) | 1992-06-03 | — | — | EP | claimed |
| EP-0253303-A2 | Metal chelating resins | F. HOFFMANN-LA ROCHE AG (CH) | 1988-01-20 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12569439-B2 | Bottom-up assembly of synthetic extracellular vesicles | EXOSC10, PLTP, EXOSC9 | GSR 4404/4885RNPEP 1404/4885CPB2 2334/4885 |
| US-20070160622-A1 | Method for assembling a polymer-biologic delivery composition | CD40, FCGR3B, TNFRSF9 | GSR 4095/4885RNPEP 184/4885CPB2 875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.